Cat.No.L3400
A unique collection of 256 small molecule inhibitors used for MAPK signaling research.
Cited by 325 Publications
• A unique collection of 256 small molecule inhibitors used for MAPK signaling research.
• Targets MEK, Raf, p38 MAPK, JNK, ERK, etc.
• Structurally diverse, medicinally active, and cell permeable.
• Rich documentation with structure and customer reviews.
• NMR and HPLC validated to ensure high purity.
| Formulation | 248 compounds pre-dissolved in 10mM DMSO, 3 compound pre-dissolved in 10mM water and 5 compound pre-dissolved in 2mM DMSO | ||
|---|---|---|---|
| Container | 96 Deep Well Plate Sealed With Aluminum Foil | ||
| Stability | 12 months | -20°C | in DMSO |
| 24 months | -80°C | in DMSO | |
| Shipping | Blue ice or dry ice | ||
Application of GPCR Compound Library in liver cancer (This article was published in Nature (IF=43) and took about 15 months):
Application of Kinase Inhibitor Library in colorectal cancer (This article was published in Nature Communications (IF=11) and took about 8 months):
Application of FDA-approved Drug Library in antivirus (This article was published in Cell Research (IF=17) and took about 13 months):
Application of FDA-approved Drug Library in metabolism (This article was published in Movement Disorders (IF=8) and took about 10 months):
Application of Epigenetics Compound Library in acute lymphoblastic leukemia (This article was published in Blood (IF=16) and took about 16 months):
Application of Inhibitor Library in tumor immunology (This article was published in Cancer Immunol Res (IF=8.6) and took about 12 months):